Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Dec;66(6):1155–1158. doi: 10.1038/bjc.1992.426

Outcome of children with resistant and relapsed Hodgkin's disease.

N D James 1, J E Kingston 1, P N Plowman 1, S Meller 1, R Pinkerton 1, A Barrett 1, R Sandland 1, T J McElwain 1, J S Malpas 1
PMCID: PMC1978034  PMID: 1457357

Abstract

During the period 1974-89, 169 children with Hodgkin's disease were treated in the Paediatric Oncology Units of the Royal Marsden and St Bartholomew's Hospitals. The overall actuarial survival for the whole group was 81% at 10 years. Thirty-five of the 169 children either did not achieve a complete remission or subsequently relapsed. The estimated actuarial survival from initial relapse or failure of primary treatment was 60% at 5 years and 45% at 10 years. Over half of the patients requiring salvage therapy had declared themselves within 2 years and only 3 relapses occurred more than 3 years from diagnosis. Very few patients remain disease free long term after failure of primary and initial salvage therapy. Patients relapsing within a year of diagnosis or not achieving a complete response to primary therapy and those with disseminated relapse had a poor response to salvage therapy. A significant subgroup of patients had prolonged survival despite multiple relapses. Neither initial histology nor stage affected survival from relapse although numbers in each subgroup were small.

Full text

PDF
1155

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appelbaum F. R., Sullivan K. M., Buckner C. D., Clift R. A., Deeg H. J., Fefer A., Hill R., Mortimer J., Neiman P. E., Sanders J. E. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. J Clin Oncol. 1987 Sep;5(9):1340–1347. doi: 10.1200/JCO.1987.5.9.1340. [DOI] [PubMed] [Google Scholar]
  2. Colby T. V., Hoppe R. T., Warnke R. A. Hodgkin's disease: a clinicopathologic study of 659 cases. Cancer. 1982 May 1;49(9):1848–1858. doi: 10.1002/1097-0142(19820501)49:9<1848::aid-cncr2820490918>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  3. De Vita V. T., Jr, Hubbard S. M., Longo D. L. The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res. 1987 Nov 15;47(22):5810–5824. [PubMed] [Google Scholar]
  4. Duchesne G., Crow J., Ashley S., Brada M., Horwich A. Changing patterns of relapse in Hodgkin's disease. Br J Cancer. 1989 Aug;60(2):227–230. doi: 10.1038/bjc.1989.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Glynne-Jones R., Whitaker S. J., Plowman P. N. The 'urn' portal; an alternative to the 'mantle' portal in the chemoradiotherapy management of paediatric Hodgkin's disease. Clin Oncol (R Coll Radiol) 1990 Jul;2(4):235–240. doi: 10.1016/s0936-6555(05)80175-x. [DOI] [PubMed] [Google Scholar]
  6. Hryniuk W. M. The importance of dose intensity in the outcome of chemotherapy. Important Adv Oncol. 1988:121–141. [PubMed] [Google Scholar]
  7. Kaye S. B., Juttner C. A., Smith I. E., Barrett A., Austin D. E., Peckham M. J., McElwain T. J. Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease. Br J Cancer. 1979 Feb;39(2):168–174. doi: 10.1038/bjc.1979.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kennedy B. J., Loeb V., Jr, Peterson V. M., Donegan W. L., Natarajan N., Mettlin C. National survey of patterns of care for Hodgkin's disease. Cancer. 1985 Dec 1;56(11):2547–2556. doi: 10.1002/1097-0142(19851201)56:11<2547::aid-cncr2820561102>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  9. Mauch P. M., Weinstein H., Botnick L., Belli J., Cassady J. R. An evaluation of long-term survival and treatment complications in children with Hodgkin's disease. Cancer. 1983 Mar 1;51(5):925–932. doi: 10.1002/1097-0142(19830301)51:5<925::aid-cncr2820510527>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  10. Roach M., 3rd, Brophy N., Cox R., Varghese A., Hoppe R. T. Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease. J Clin Oncol. 1990 Apr;8(4):623–629. doi: 10.1200/JCO.1990.8.4.623. [DOI] [PubMed] [Google Scholar]
  11. Robinson B., Kingston J., Nogueira Costa R., Malpas J. S., Barrett A., McElwain T. J. Chemotherapy and irradiation in childhood Hodgkin's disease. Arch Dis Child. 1984 Dec;59(12):1162–1167. doi: 10.1136/adc.59.12.1162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Russell K. J., Donaldson S. S., Cox R. S., Kaplan H. S. Childhood Hodgkin's disease: patterns of relapse. J Clin Oncol. 1984 Feb;2(2):80–87. doi: 10.1200/JCO.1984.2.2.80. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES